Article
Activation of human dendritic cells by recombinant modified vaccinia virus Ankara vectors encoding survivin and IL-2 genes in vitro.
Human gene therapy - 1 Jan 2010
Tao Ran, Li Lian, Huang Wenlin, Zheng Limin
Abstract excerpt
Modified vaccinia virus Ankara (MVA) has attracted significant attention as a safe, promising vector for immunotherapy. However, the precise effects of MVA infection on immune responses in humans remain largely unknown. We constructed recombinant MVA (rMVA) encoding both a human tumor-associated antigen (survivin) and the proinflammatory cytokine interleukin (IL)-2 and investigated their effects on human...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
